Singapore markets close in 2 hours 12 minutes

Organogenesis Holdings Inc. (ORGO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
9.95-0.52 (-4.97%)
At close: 1:00PM EST
9.95 0.00 (0.00%)
After hours: 01:09PM EST
Sign in to post a message.
  • C
    CHARLES
    Great Earnings! It is a hold for me.
  • F
    Frank
    WS hates this stock. It exceeds earning every quarter but it goes down every time. Unbelievable
  • m
    mark
    Buying more should go to $21 soon
  • P
    Pim
    The Affinity product is indeed important for Organogenesis.

    Organogenesis Holdings' (ORGO) CEO Gary Gillheeney on Q2 2021 Results - Earnings Call

    "Sure. Thank you, Ryan. Yes, we did have a nice increase in capacity in Q2 for our Affinity in amnion products. So that was something that we were counting on. And we actually focused a lot of our attention commercially on driving and expanding our Affinity sales and expanding the launch of that product as a result of that capacity. So that was a nice bump for the quarter for us for sure. "

    But If the situation VIC alleges indeed ended in July, the very positive 2021 guidance ( dated August 2021) should still apply. Further I wonder about the USD 250 M overbilling to the Feds.

    The market reaction is quite tough so far and the current downtrend continues with such force that I wonder what is going on here. Management was so upbeat in their future expectations.

    Until this news item I was most worried about this issue that still hangs above the market:

    Organogenesis Holdings' (ORGO) CEO Gary Gillheeney on Q2 2021 Results - Earnings Call
    "as we stated in the 8-K our large legacy shareholders that hold over 40% of Organogenesis stock, which is Alan Ades, Alberta Erani, Dennis Erani, Glenn Nussdorf in related trusting companies that they control have agreed with the company, effective August 9, that they will not sell any shares of the company’s capital stock, that they hold until at least March 1, 2022 unless any such sale is completed in an orderly fashion as part of an underwritten secondary public offering. The company recognized and I wasn’t really happy with the sales, I’m sure most people weren’t. So, the board has agreed that they recognize that periodic and unexpected selling by them in the market may cause some volatility or disruption. So, their entry into the lockup reflects their commitment to conduct any of these sales, at least through March of 2022, in an orderly fashion. So, I think the recognition, that they could create some disruption in the market is certainly unintended and needs to be addressed. And we addressed it."

    Hope management clarifies the current situation soon.
  • m
    mark
    Glad to see no one is buying into phony investigations
  • M
    Martini_lv
    Whoever fell for this bogus "report" will regret selling it here.
    There are also other firms like Citron Research who accumulate large short position on companies and then issue a bogus statements full of inaccuracies to drive the price down short term and close out their short position or make their sold puts expire.
    Professional criminals that SEC does nothing about.
  • m
    mark
    OMG !!! It’s a Ambulance Chaser’s Convention
  • m
    mark
    Major Analysts are saying STRONG BUY
  • I
    Ion Dragoș
    this is gona Vly Up Today
  • P
    Pim
    Shares of Organogenesis (ORGO -18.4%) are down after a short report from Value Investors Club accuses the company of "ripping off" the federal government with reimbursement.
    Value Investor Club ("VIC") alleges the wound care company has been improperly billing the feds for $250M per year.
    VIC further says that the company set the price of its new amnion wound covering Affinity "exorbitantly high" which Medicare reimbursed.
    In addition, the report alleges that the company had been proving large rebates to doctors for Affinity, making it lucrative for doctors to use.
    However, VIC says that came to end in July when CMS set a new price for Affinity.
  • J
    Jab A
    Guys according to my linear regression calculations and prior monthly support buy only at 8.05. If 15 min candle closes below 8 you better get out. But you can bounce play this at 9 if it reaches there today. But do not hold overnight. Tomorrow will be another fall. Unless it hits 8 today(highly unlikely).
  • K
    Ken
    Ok what is going on here? Why this big of a drop on no news?
  • k
    kevin w
    is this all wound care products? bandages and what else? can't fish through the website very easily.
  • m
    mark
    Does anyone know why the drop
  • m
    mark
    Fake News!!!
    They aren’t involved in Medicarebilling
  • e
    eleazar
    Defrauding/over billing medicare is a serious allegation. Bribing doctors to prescribe your product is also serious. Wish these be investigated thoroughly.
  • a
    alan
    Earnings around the corner what a bargain this is right now
  • e
    eleazar
    Lower highs, lower lows, a trend you should pay attention to.
  • m
    mark
    Buying more will go to $26 pass this on
  • G
    Grumpy
    This #$%$ is going below $1